Search results
Results from the WOW.Com Content Network
Less common causes of OAB are anatomical defects from birth or injury, an illness like bladder cancer, or as a side effect of some cardiovascular medications, Dr. Ramin adds. If your bladder ...
Cisplatin and gemcitabine treatment may be associated with less severe side effects. [5] Up to half of people with bladder cancer are not able to take these chemotherapy treatments due to their overall health. Taxanes or vinflunine have been used as second-line therapy (after progression on a platinum containing chemotherapy). [16]
Bladder cancer is most common in wealthier regions of the world, where exposure to certain carcinogens is highest. It is also common in places where schistosome infection is common, such as North Africa. [47] Bladder cancer is much more common in men than women; around 1.1% of men and 0.27% of women develop bladder cancer. [2]
Di Bella Therapy – a cocktail of vitamins, drugs and hormones devised by Luigi di Bella (1912–2003) and promoted as a cancer treatment. According to the American Cancer Society: "Available scientific evidence does not support claims that Di Bella therapy is effective in treating cancer. It can cause serious and harmful side effects. ...
Serious side effects were reported by 67% of Trodelvy patients and 76% of chemotherapy patients. The most common side effects for Trodelvy were fatigue, diarrhea and hair loss.
Treatment depends on the type of neurogenic bladder and other medical problems. Treatment strategies include catheterization, medications, surgeries or other procedures. The goals of treatment focus on preserving the structure and function of the upper urinary tract, and on improving the quality of life for patients with neurogenic bladder. [2]
Cancer treatments are a wide range of treatments available for the many different types of cancer, with each cancer type needing its own specific treatment. [1] Treatments can include surgery, chemotherapy, radiation therapy, hormonal therapy, targeted therapy including small-molecule drugs or monoclonal antibodies, [2] and PARP inhibitors such as olaparib. [3]
Long term: Frequent urination, loss of bladder control, urinary tract infection [1] Types: Acute, chronic [1] Causes: Blockage of the urethra, nerve problems, certain medications, weak bladder muscles [1] Diagnostic method: Amount of urine in the bladder post urination [1] Treatment: Catheter, urethral dilation, urethral stents, surgery [1 ...